HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Feng Ding Selected Research

Immunotherapy

1/2021Tumour targetable and microenvironment-responsive nanoparticles simultaneously disrupt the PD-1/PD-L1 pathway and MAPK/ERK/JNK pathway for efficient treatment of colorectal cancer.
1/2018Lycium barbarum Polysaccharide Promotes Maturation of Dendritic Cell via Notch Signaling and Strengthens Dendritic Cell Mediated T Lymphocyte Cytotoxicity on Colon Cancer Cell CT26-WT.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Feng Ding Research Topics

Disease

45Neoplasms (Cancer)
01/2024 - 11/2008
23Type 2 Diabetes Mellitus (MODY)
04/2024 - 01/2016
19Inflammation (Inflammations)
01/2024 - 11/2003
19Acute Kidney Injury (Acute Renal Failure)
01/2021 - 01/2008
17Alzheimer Disease (Alzheimer's Disease)
04/2024 - 11/2003
14Infections
06/2023 - 09/2010
11Chronic Renal Insufficiency
12/2022 - 09/2012
10Neurodegenerative Diseases (Neurodegenerative Disease)
01/2024 - 11/2003
9Sepsis (Septicemia)
01/2024 - 01/2010
9Amyloidosis
02/2023 - 03/2016
8Parkinson Disease (Parkinson's Disease)
01/2024 - 08/2008
7Critical Illness (Critically Ill)
01/2022 - 01/2013
6Amyloid Plaque
02/2024 - 03/2016
6Chronic Kidney Failure (Chronic Renal Failure)
06/2021 - 01/2010
6Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2021 - 11/2003
6Carcinogenesis
01/2020 - 11/2008
5Fibrosis (Cirrhosis)
12/2023 - 01/2016
5Breast Neoplasms (Breast Cancer)
03/2023 - 04/2016
5COVID-19
01/2023 - 01/2022
4Liver Failure
05/2024 - 09/2020
4Neoplasm Metastasis (Metastasis)
08/2023 - 04/2013
4Bacterial Infections (Bacterial Infection)
01/2023 - 09/2010
4Wounds and Injuries (Trauma)
01/2022 - 07/2010
4Chronic Hepatitis B
11/2021 - 03/2015
4Kidney Diseases (Kidney Disease)
07/2021 - 10/2015
4Lung Neoplasms (Lung Cancer)
10/2020 - 01/2014
4Nervous System Diseases (Neurological Disorders)
10/2020 - 03/2016
4Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 02/2015
4Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2015 - 01/2013
3Mitochondrial Diseases (Mitochondrial Disease)
12/2023 - 01/2019
3Dementia (Dementias)
02/2023 - 11/2019
3Hypoxia (Hypoxemia)
01/2023 - 05/2016
3Hepatocellular Carcinoma (Hepatoma)
01/2023 - 05/2016
3Disease Progression
01/2023 - 01/2018
3Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 04/2018
3Glioma (Gliomas)
01/2020 - 12/2015
3Drug-Related Side Effects and Adverse Reactions
01/2020 - 01/2018
3Poisoning
12/2019 - 04/2004
3Prion Diseases (Transmissible Spongiform Encephalopathies)
10/2017 - 11/2003
2Cardiovascular Diseases (Cardiovascular Disease)
05/2024 - 01/2022
2Cognitive Dysfunction
02/2024 - 03/2008
2Liver Cirrhosis (Hepatic Cirrhosis)
01/2024 - 01/2021
2Virus Diseases (Viral Diseases)
12/2023 - 08/2023
2Carcinoma (Carcinomatosis)
01/2023 - 12/2018
2Residual Neoplasm
01/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

44Proteins (Proteins, Gene)FDA Link
02/2023 - 02/2002
29Amyloid (Amyloid Fibrils)IBA
05/2024 - 11/2003
18Islet Amyloid PolypeptideIBA
04/2024 - 01/2016
13Biomarkers (Surrogate Marker)IBA
10/2023 - 03/2015
13Peptides (Polypeptides)IBA
08/2023 - 03/2016
10Amyloid beta-PeptidesIBA
01/2024 - 01/2015
10CytokinesIBA
11/2022 - 11/2003
8AlbuminsIBA
01/2023 - 01/2005
7RNA (Ribonucleic Acid)IBA
02/2024 - 01/2014
7CreatinineIBA
07/2021 - 03/2012
6DNA (Deoxyribonucleic Acid)IBA
10/2023 - 11/2003
6Messenger RNA (mRNA)IBA
07/2022 - 02/2002
6Uremic ToxinsIBA
01/2022 - 01/2019
6MicroRNAs (MicroRNA)IBA
10/2020 - 12/2015
5Interleukin-6 (Interleukin 6)IBA
01/2024 - 02/2018
5Hepatitis B Surface Antigens (HBsAg)FDA Link
06/2023 - 12/2015
5Citric Acid (Citrate)FDA LinkGeneric
06/2022 - 04/2011
5Liposomes (Liposome)IBA
01/2022 - 12/2015
5Prealbumin (Transthyretin)IBA
06/2021 - 01/2009
5Superoxide Dismutase-1IBA
01/2021 - 11/2003
5Small Interfering RNA (siRNA)IBA
01/2021 - 12/2015
5Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2019
4CalciumIBA
05/2024 - 01/2005
4Amyloidogenic ProteinsIBA
01/2024 - 09/2017
4salicylhydroxamic acid (SHAM)IBA
12/2023 - 01/2010
4LipidsIBA
12/2023 - 01/2017
4AcidsIBA
08/2023 - 03/2020
4Long Noncoding RNAIBA
01/2023 - 05/2016
4AntibodiesIBA
10/2020 - 12/2015
3IronIBA
01/2024 - 06/2019
3alpha-SynucleinIBA
01/2024 - 10/2017
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2024 - 02/2018
3Insulin (Novolin)FDA Link
12/2023 - 01/2016
3SynucleinsIBA
12/2023 - 11/2022
3BilirubinIBA
09/2023 - 03/2022
3Reactive Oxygen Species (Oxygen Radicals)IBA
08/2023 - 12/2017
3gamma- hydroxy- gamma- ethyl- gamma- phenylbutyramide (HEPB)IBA
08/2023 - 11/2022
3Hepatitis B Vaccines (Hepatitis B Vaccine)IBA
06/2023 - 12/2020
3EnzymesIBA
01/2021 - 09/2019
3ErbB Receptors (EGF Receptor)IBA
10/2020 - 11/2016
3Tissue Inhibitor of Metalloproteinase-2IBA
04/2018 - 02/2007
2Doxorubicin (Adriamycin)FDA LinkGeneric
04/2024 - 09/2016
2ApolipoproteinsIBA
01/2024 - 10/2013
2AntioxidantsIBA
01/2024 - 01/2015
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2023 - 09/2010
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2023 - 02/2007
2Anti-Bacterial Agents (Antibiotics)IBA
01/2023 - 01/2018
2Phenobarbital (Luminal)FDA Link
01/2023 - 11/2016

Therapy/Procedure

27Therapeutics
01/2023 - 01/2005
13Renal Dialysis (Hemodialysis)
05/2024 - 01/2005
5Drug Therapy (Chemotherapy)
01/2024 - 05/2016
3Peritoneal Dialysis
05/2024 - 06/2011
3Aftercare (After-Treatment)
08/2023 - 01/2020
3Continuous Renal Replacement Therapy
06/2020 - 01/2013
3Renal Replacement Therapy (Therapies, Renal Replacement)
12/2019 - 09/2011